Contact investigation for tuberculosis: a systematic review and meta-analysis
GJ Fox, SE Barry, WJ Britton… - European Respiratory …, 2013 - Eur Respiratory Soc
Investigation of contacts of patients with tuberculosis (TB) is a priority for TB control in high-
income countries, and is increasingly being considered in resource-limited settings. This …
income countries, and is increasingly being considered in resource-limited settings. This …
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting
economically active young adults, and has high mortality irrespective of HIV status. In some …
economically active young adults, and has high mortality irrespective of HIV status. In some …
Transmission of extensively drug-resistant tuberculosis in South Africa
NS Shah, SC Auld, JCM Brust… - … England Journal of …, 2017 - Mass Medical Soc
Background Drug-resistant tuberculosis threatens recent gains in the treatment of
tuberculosis and human immunodeficiency virus (HIV) infection worldwide. A widespread …
tuberculosis and human immunodeficiency virus (HIV) infection worldwide. A widespread …
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives
N Dookie, SL Ngema, R Perumal… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Drug-resistant tuberculosis (DR-TB) remains a global crisis due to the increasing incidence
of drug-resistant forms of the disease, gaps in detection and prevention, models of care, and …
of drug-resistant forms of the disease, gaps in detection and prevention, models of care, and …
[HTML][HTML] Preventive therapy for latent tuberculosis infection—the promise and the challenges
Around one third of the world's population may harbour latent tuberculosis infection (LTBI),
an asymptomatic immunological state that confers a heightened risk of subsequently …
an asymptomatic immunological state that confers a heightened risk of subsequently …
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination
R Diel, R Loddenkemper, JP Zellweger… - European …, 2013 - Eur Respiratory Soc
The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB
drugs pipeline together with the development of a new World Health Organization Strategy …
drugs pipeline together with the development of a new World Health Organization Strategy …
Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis
Contact investigations among individuals living with drug-susceptible tuberculosis patients
(source cases) have shown a high yield of tuberculosis disease and latent tuberculosis, but …
(source cases) have shown a high yield of tuberculosis disease and latent tuberculosis, but …
Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study
L Grandjean, RH Gilman, L Martin, E Soto… - PLoS …, 2015 - journals.plos.org
Background The “fitness” of an infectious pathogen is defined as the ability of the pathogen
to survive, reproduce, be transmitted, and cause disease. The fitness of multidrug-resistant …
to survive, reproduce, be transmitted, and cause disease. The fitness of multidrug-resistant …
Treatment of latent tuberculosis infection—an update
MA Huaman, TR Sterling - Clinics in chest medicine, 2019 - chestmed.theclinics.com
Latent tuberculosis infection (LTBI) is defined by the presence of detectable immune
responses to Mycobacterium tuberculosis antigens with no clinical evidence of active TB …
responses to Mycobacterium tuberculosis antigens with no clinical evidence of active TB …